Peak Retirement Planning Inc. Has $1.79 Million Holdings in Colgate-Palmolive Company $CL

Peak Retirement Planning Inc. increased its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 42.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,404 shares of the company’s stock after buying an additional 6,723 shares during the quarter. Peak Retirement Planning Inc.’s holdings in Colgate-Palmolive were worth $1,791,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Asset Management One Co. Ltd. lifted its holdings in Colgate-Palmolive by 3.9% in the third quarter. Asset Management One Co. Ltd. now owns 422,292 shares of the company’s stock valued at $33,758,000 after buying an additional 16,017 shares during the period. Cidel Asset Management Inc. grew its stake in shares of Colgate-Palmolive by 13.6% during the second quarter. Cidel Asset Management Inc. now owns 329,060 shares of the company’s stock worth $29,912,000 after purchasing an additional 39,413 shares during the period. Vanguard Group Inc. lifted its stake in Colgate-Palmolive by 1.2% in the second quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock valued at $7,522,129,000 after buying an additional 993,432 shares during the period. Sequoia Financial Advisors LLC boosted its holdings in Colgate-Palmolive by 18.6% during the second quarter. Sequoia Financial Advisors LLC now owns 30,273 shares of the company’s stock worth $2,752,000 after buying an additional 4,738 shares during the last quarter. Finally, Exchange Traded Concepts LLC grew its position in shares of Colgate-Palmolive by 15.0% during the 3rd quarter. Exchange Traded Concepts LLC now owns 400,137 shares of the company’s stock worth $31,987,000 after buying an additional 52,261 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive News Roundup

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Large-cap brokers raised targets/ratings — Bank of America moved its target to $100 and kept a Buy rating (about ~9% upside), signaling confidence in the company’s growth drivers. Bank of America raises PT to $100
• Positive Sentiment: Evercore lifted its target to $100 and set an Outperform rating, another high-profile shop adding upside to consensus. Evercore raises PT to $100
• Positive Sentiment: JPMorgan raised its price target to $97 and put CL at Overweight, adding institutional weight behind the post-earnings view. JPMorgan raises PT to $97
• Positive Sentiment: Colgate reported Q4 results that beat estimates (EPS $0.95 vs. $0.91 expected; revenue $5.23B vs. $5.13B expected) and organic sales growth, which prompted analysts to boost forecasts. Earnings strength is the primary catalyst for the upgrades. Analysts Boost Forecasts After Q4 Beat
• Positive Sentiment: Sell-side commentary (TD Cowen, Bank of America research notes) emphasizes premiumization, emerging-market strength and pet nutrition as multi-year growth levers supporting Buy ratings. Analyst thematic support
• Neutral Sentiment: Jefferies raised its target modestly to $91 but keeps a Hold rating; the new target is near the current price, implying limited near-term upside. Jefferies raises PT to $91 (Hold)
• Neutral Sentiment: Deutsche Bank raised its target to $90 and remains a Hold, another signal that some shops see less immediate upside despite the beat. Deutsche Bank raises PT to $90
• Negative Sentiment: Press coverage highlights lingering consumer uncertainty that could pressure volumes/mix going forward, a reminder that macro headwinds remain despite the beat. Consumer uncertainty clouds outlook

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $91.75 on Tuesday. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.42 and a quick ratio of 0.27. The firm has a market cap of $73.96 billion, a price-to-earnings ratio of 35.02, a price-to-earnings-growth ratio of 6.09 and a beta of 0.29. The stock’s 50-day moving average is $81.02 and its 200-day moving average is $81.37. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $100.18.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The business had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.Colgate-Palmolive’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.91 EPS. Equities analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be issued a dividend of $0.52 per share. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 annualized dividend and a yield of 2.3%. Colgate-Palmolive’s dividend payout ratio is presently 79.39%.

Analysts Set New Price Targets

Several research analysts recently weighed in on CL shares. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. TD Cowen restated a “buy” rating on shares of Colgate-Palmolive in a research report on Monday. Evercore ISI lifted their target price on Colgate-Palmolive from $94.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday. Citigroup increased their price target on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Monday. Finally, Argus reiterated a “hold” rating on shares of Colgate-Palmolive in a report on Thursday, December 11th. Eleven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $94.13.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.